Voltage-dependent T-type calcium channel subunit alpha-1H — Drug Target

All drugs that target Voltage-dependent T-type calcium channel subunit alpha-1H — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

Dihydropyridine Calcium Channel Blocker [EPC] · Dihydropyridine Calcium Channel Blocker

Marketed (2)

• Plendil · AstraZeneca · Dihydropyridine Calcium Channel Blocker [EPC] · Cardiovascular
  Plendil works by blocking calcium channels in blood vessel walls, causing them to relax and widen, which lowers blood pressure.
• Cardene · Hikma Intl Pharms · Dihydropyridine Calcium Channel Blocker · Cardiovascular
  Cardene works by blocking calcium channels in the heart and blood vessels, which helps to relax and widen blood vessels, reducing blood pressure and heart workload.

Phase 2 pipeline (1)

• Zeria · Cardiovascular
  Zeria works by blocking the T-type calcium channel, which helps to relax blood vessels and lower blood pressure.